α受体阻滞剂在高血压合并良性前列腺增生症中的作用

Role of Alpha Blockers in Hypertension with Benign Prostatic Hyperplasia.

作者信息

Mathur R P, Nayak Sumanlata, Sivaramakrishnan R, Jain Vikas

出版信息

J Assoc Physicians India. 2014 Sep;62(9 Suppl):40-4.

Abstract

Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.

摘要

高血压和良性前列腺增生（BPH）是老年男性的常见疾病。随着世界人口老龄化，这两种疾病正成为全球重大的公共卫生问题。接受BPH治疗的男性中约有30%同时患有高血压。α-肾上腺素能阻滞剂：哌唑嗪、特拉唑嗪和多沙唑嗪是治疗高血压的常用药物，也是治疗BPH的有效药物。将α-肾上腺素能阻滞剂作为高血压合并BPH男性的首选治疗方法是合理的。